Satter Muneer A bought 613,497 shares of Annexon, Inc. at $5.41 for $3.32M on May 28, 2026

Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Director
DIR
Filed May 29, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$3,319,018.77Shares × reported price
Shares traded
613,497Common Stock
Price per share
$5.41Reported price. Read footnotes for ranges.
% of reported position traded
6.31%This security and ownership context
Holdings after
10,342,134Indirect · See footnote
Trade date
May 28, 2026Buy
Filed
May 29, 2026, 5:21 PM ET1-day reporting delay
Accession
0001315797-26-000001Code P · Transaction 94178
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 9,728,637 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

ANNX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
ANNX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +11%1w ago +0.4%1d ago −0.6%
Returns since7d −2.4%30d +1.1%90d180d1y

Footnotes in full

F1: All shares were purchased by Alerce Medical Technology Partners, L.P. ("Alerce Medical"). The Reporting Person has sole voting and dispositive power over the shares held by Alerce Medical. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein. F2: As of May 28, 2026, includes (a) 240,000 shares that are held by the Muneer A. Satter Revocable Trust for which the Reporting Person serves as trustee and, in such capacity, has sole voting and dispositive power over all such shares, (b) 567,240 shares that are held by various other trusts and entities for which the Reporting Person serves as trustee, investment advisor or manager, as applicable, and, in each such capacity, has sole voting and dispositive power over all such shares, (c) 1,147,738 shares that are held by Satter Medical Technology Partners, L.P. for which the Reporting Person has sole voting and dispositive power over all such shares and (d) 8,387,156 shares that are held by Alerce Medical for which the Reporting Person has sole voting and dispositive power over all such shares. The Reporting Person disclaims beneficial ownership of all shares included under (b), (c) and (d) of this footnote, except to the extent of his pecuniary interest therein.